World Health Organization Guidelines for the Treatment of Multidrug-Resistant Tuberculosis
Letter to Dr. Tedros Adhanom Ghebreyesus, Director-General, WHO, and Dr. Tereza Kasaeva, Global TB Program Director.
Forging A Path to HCV Elimination: Simpler Tests and Affordable Generics
In July 2017, 37 treatment activists from 17 countries—including 14 low- and middle-income countries (LMICs)—met with representatives from three generics and three diagnostics companies. This Hepatitis C World Community Advisory Board meeting was an opportunity for activists to present demands…
Expanding the Use of the TB LAM Test for People with HIV
TAG and partners hosted this webinar on October 3, 2017. Speakers included Lynette Mabote, AIDS & Rights Alliance for Southern Africa; Lindiwe Mvusi, Department of Health, Republic of South Africa; Stephen Wanjala, MSF; and Wayne van Gemert, Global Drug Facility…
Open Letter: Hosting Union World Conferences on Lung Health in High-Burden Countries
Letter from individuals and organizations, including TAG, expressing concern over selection of host cities to host World Conferences on Lung Health.
Letter Calling on The Union to Retire Stigmatizing and Criminalizing Language
TAG, CRAG, and other civil society organizations sent this letter to The Union, asking them, as producers of the world’s largest TB conference and publisher of the field’s flagship journal to lead by example...
Research Fundamentals for Activists
The goal of the Research Fundamentals booklet is to build the research literacy of activists, so they can engage in evidence - based advocacy with: an increased understanding of research concepts, processes and results; an awareness of the value of…
Childhood TB Advocacy Meeting Presentations
On January 5, 2012, TAG held a Childhood TB Federal Advocacy Meeting in Washington, D.C. The meeting was cosponsored by STOP TB, RESULTS/ACTION, the Center for Global Health Policy, and the American Thoracic Society (ATS). Some of the highlights of the…